ABSI logo

Absci (ABSI)

Profile

Full Name

Absci Corporation

Ticker Symbol

NASDAQ: ABSI

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

July 22, 2021

Indexes

Not included

Website

http://www.absci.com

Employees

156

Key Details

Price

$2.77(+2.97%)

Market cap

$353.34M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$4.53M(-20.71% YoY)

Annual EPS

-$0.94(+21.67% YoY)

PE ratio

-

Next earnings date

Aug 14, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $2.77
    ABSI price is $2.77

    30-Day Relative Volume

    0.81
    ABSI 30-day relative volume is 0.81

    Price Performance

    Price Most recent change

    +2.97%
    ABSI price was up +2.97% on Jul 3, 2025

    Price YTD change

    +5.73%
    ABSI price is up +5.73% since January 1st

    Price 1-year change

    -12.89%
    ABSI price is down -12.89% year-on-year

    Price 3-year change

    -16.82%
    ABSI price is down -16.82% over the past 3 years

    Price Range

    Price All-time high

    $31.53
    ABSI price is currently -91.21% below its historical high of $31.53

    Price 3-year low

    $1.11
    ABSI price is currently +149.32% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $353.34M
    ABSI market capitalization is $353.34 million

    Market cap 3-year change

    +14.36%
    ABSI market capitalization is up +14.36% over the past 3 years

    Market cap All-time high

    $2.79B
    ABSI market capitalization is currently -87.35% below its historical high of $2.79 billion

    Market cap sector rank

    61.28%
    ABSI market capitalization is higher than 61.28% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +12.44%
    ABSI shares outstanding is up +12.44% year-on-year

    Shares Outstanding 3-Year Change

    +37.48%
    ABSI shares outstanding is up +37.48% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.96
    ABSI beta is 1.96

    200-day SMA

    $3.36
    ABSI price is currently -17.58% below its 200-day simple moving average

    50-day SMA

    $2.84
    ABSI price is currently -2.40% below its 50-day simple moving average

    RSI

    50.15
    ABSI 14-day relative strength index is 50.15

    Volume

    0.81
    ABSI 30-day relative volume is 0.81

    ATR

    $0.16
    ABSI average true range is $0.16

    10-day Historical Volatility

    38.12%
    ABSI 10-day historical volatility is 38.12%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $4.53M
    ABSI annual revenue is $4.53 million

    Revenue Analysts estimate

    $10.51M
    ABSI annual revenue is currently -56.85% lower than the consensus analysts' forecast

    Revenue 1-year change

    -20.71%
    ABSI annual revenue is down -20.71% year-on-year

    Revenue Sector rank

    20.84%
    ABSI annual revenue is higher than 20.84% of companies in Healthcare sector

    EPS

    EPS

    -$0.94
    ABSI annual earnings per share is -$0.94

    EPS Analysts estimate

    -$0.79
    ABSI annual earnings per share is currently +18.34% higher than the consensus analysts' forecast

    EPS 1-year change

    +21.67%
    ABSI annual earnings per share is up +21.67% year-on-year

    EPS Sector rank

    57.54%
    ABSI annual earnings per share is higher than 57.54% of companies in Healthcare sector

    Profit

    Gross profit

    -
    ABSI annual gross profit value is unknown

    Gross margin

    -
    ABSI annual gross profit margin value is unknown

    Operating profit

    -$108.89M
    ABSI annual operating income is -$108.89 million

    Operating margin

    -2401.59%
    ABSI annual operating profit margin is -2401.59%

    Net income

    -$103.11M
    ABSI annual net profit is -$103.11 million

    Net margin

    -2274.06%
    ABSI annual net profit margin is -2274.06%

    Expenses

    Total expenses

    $113.42M
    ABSI annual total expenses is $113.42 million

    Operating expenses

    $113.42M
    ABSI annual total operating expenses is $113.42 million

    Cost of goods sold

    -
    ABSI annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $36.17M
    ABSI annual SGA is $36.17 million

    Depreciation and amortization

    $13.39M
    ABSI annual depreciation & amortization is $13.39 million

    Interest expense

    $565.00K
    ABSI annual interest expense is $565.00 thousand

    Income tax

    $70.00K
    ABSI annual income tax is $70.00 thousand

    EBIT & EBITDA

    EBIT

    -$102.47M
    ABSI annual earnings before interest & taxes is -$102.47 million

    EBITDA

    -$89.08M
    ABSI annual EBITDA is -$89.08 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $213.61M
    ABSI annual total assets is $213.61 million

    Non current assets

    $79.78M
    ABSI annual long term assets is $79.78 million

    Current assets

    $133.83M
    ABSI annual total current assets is $133.83 million

    Cash and cash equivalents

    $41.21M
    ABSI annual cash & cash equivalents is $41.21 million

    Accounts receivable

    $0.00
    ABSI annual accounts receivable is $0.00

    Inventory

    -
    ABSI annual inventory value is unknown

    Liabilities

    Total liabilities

    $34.48M
    ABSI annual total liabilities is $34.48 million

    Long term liabilities

    $5.82M
    ABSI annual total long term liabilities is $5.82 million

    Current liabilities

    $28.66M
    ABSI annual total current liabilities is $28.66 million

    Accounts payable

    $3.53M
    ABSI annual accounts payable is $3.53 million

    Debt

    Total debt

    $10.11M
    ABSI annual total debt is $10.11 million

    Total debt 1-year change

    -36.37%
    ABSI annual total debt is down -36.37% year-on-year

    Long term debt

    $5.69M
    ABSI annual long term debt is $5.69 million

    Short term debt

    $4.42M
    ABSI annual short term debt is $4.42 million

    Equity & Capital

    Shareholders equity

    $179.13M
    ABSI annual stockholders equity is $179.13 million

    Book value

    $179.13M
    ABSI annual book value is $179.13 million

    Retained earnings

    -$509.60M
    ABSI annual retained earnings is -$509.60 million

    Working capital

    $105.17M
    ABSI annual working capital is $105.17 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$72.40M
    ABSI annual cash flow from operations is -$72.40 million

    Cash from operations 1-year change

    -12.01%
    ABSI annual cash flow from operations is down -12.01% year-on-year

    Cash from investing

    -$41.58M
    ABSI annual cash flow from investing activities is -$41.58 million

    Cash from investing 1-year change

    -150.74%
    ABSI annual cash flow from investing activities is down -150.74% year-on-year

    Cash from financing

    $82.53M
    ABSI annual cash flow from financing activities is $82.53 million

    Cash from financing 1-year change

    +1940.87%
    ABSI annual cash flow from financing activities is up +1940.87% year-on-year

    CAPEX

    CAPEX

    $404.00K
    ABSI annual capital expenditures is $404.00 thousand

    CAPEX 1-year change

    -53.02%
    ABSI annual capital expenditures is down -53.02% year-on-year

    Free Cash Flow

    Free cash flow

    -$72.81M
    ABSI annual free cash flow is -$72.81 million

    Free cash flow 1-year change

    -11.16%
    ABSI annual free cash flow is down -11.16% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    ABSI annual gross profit margin value is unknown

    Operating margin

    -2401.59%
    ABSI annual operating profit margin is -2401.59%

    Net margin

    -2274.06%
    ABSI annual net profit margin is -2274.06%

    ROA & ROE

    ROA

    -47.86%
    ABSI annual return on assets is -47.86%

    ROE

    -58.04%
    ABSI annual return on equity is -58.04%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    ABSI price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    ABSI price to earnings ratio is unknown

    PB Ratio

    PB ratio

    1.78
    ABSI price to book ratio is 1.78

    PB ratio Sector rank

    54.19%
    ABSI price to book ratio is higher than 54.19% of companies in Healthcare sector

    PS Ratio

    PS ratio

    73.38
    ABSI price to sales ratio is 73.38

    PS ratio Sector rank

    93.64%
    ABSI price to sales ratio is higher than 93.64% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $315.26M
    ABSI enterprise value is $315.26 million

    Enterprise value Sector rank

    60.13%
    ABSI enterprise value is higher than 60.13% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -3.36
    ABSI EV/EBITDA is -3.36

    EV/EBITDA Sector rank

    29.78%
    ABSI EV/EBITDA is higher than 29.78% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    4.67
    ABSI annual current ratio is 4.67

    Quick ratio

    -
    ABSI annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.02
    ABSI annual debt to equity ratio is 0.02

    Interest coverage ratio

    -181.36
    ABSI annual interest coverage ratio is -181.36

    Risk & Stability

    Piotroski F-Score

    -
    ABSI piotroski f-score value is unknown

    Altman Z-Score

    1.84
    ABSI altman z-score is 1.84

    Analyst ratings

    Recent major analysts updates

    May 14, 25 Needham
    Buy
    Apr 16, 25 Keybanc
    Overweight
    Apr 9, 25 Needham
    Buy
    Mar 20, 25 Guggenheim
    Buy
    Mar 19, 25 Needham
    Buy
    Mar 19, 25 HC Wainwright & Co.
    Buy
    Jan 22, 25 Needham
    Buy
    Jan 17, 25 HC Wainwright & Co.
    Buy
    Jan 10, 25 HC Wainwright & Co.
    Buy
    Jan 8, 25 Keybanc
    Overweight

    Institutional Ownership

    Screeners with ABSI included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Stocks below SMA 200
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Absci?
    • Does Absci pay dividends?
    • What sector is Absci in?
    • What industry is Absci in?
    • What country is Absci based in?
    • When did Absci go public?
    • Is Absci in the S&P 500?
    • Is Absci in the NASDAQ 100?
    • Is Absci in the Dow Jones?
    • When was Absci's last earnings report?
    • When does Absci report earnings?

    What is the ticker symbol for Absci?

    The ticker symbol for Absci is NASDAQ:ABSI

    Does Absci pay dividends?

    No, Absci does not pay dividends

    What sector is Absci in?

    Absci is in the Healthcare sector

    What industry is Absci in?

    Absci is in the Biotechnology industry

    What country is Absci based in?

    Absci is headquartered in United States

    When did Absci go public?

    Absci's initial public offering (IPO) was on July 22, 2021

    Is Absci in the S&P 500?

    No, Absci is not included in the S&P 500 index

    Is Absci in the NASDAQ 100?

    No, Absci is not included in the NASDAQ 100 index

    Is Absci in the Dow Jones?

    No, Absci is not included in the Dow Jones index

    When was Absci's last earnings report?

    Absci's most recent earnings report was on May 13, 2025

    When does Absci report earnings?

    The next expected earnings date for Absci is August 14, 2025
    On this page